← back to database
Pender Ventures invests in Canadian B2B software and healthtech companies at the inflection point between commercialization and scale. It is stage-agnostic but identifies Series A as its typical sweet spot, prefers to lead priced rounds, and can invest across North America.
Primary stage
Lead / follow
Initial check size
Ownership target
Specialization
Generalist / Specialist
Specialist
Latest fund size
C$100 million+ Pender Technology Inflection Fund II
Latest fund vintage
2024
Investing team
- Maria PacellaManaging Partner
- Meryeme LahmamiPrincipal
- Cheri CorbettPartner
- Jacob GraingerAssociate
- Everett JuurlinkAnalyst
- Lizzie HnatiukAnalyst and AI Lead
How to reach them
Notable investments
Jane App, Clarius Mobile Health, Checkfront, DrugBank, Swift Medical, Copperleaf, DistillerSR, Traction Complete